SciClone Pharmaceuticals, Inc. (SCLN)

kaleidoscopic (< 20) Submitted: 11/12/2009 2:53:25 PM : Start Price: $2.67 SCLN Score: -8.52

Unsinnige forschlag von Hoffy 09.11.12

TraderHater (44.87) Submitted: 11/6/2009 3:21:51 PM : Start Price: $2.94 SCLN Score: +19.16

Apparently, the key to making good calls is just short the hell out of all the penny stocks

yooperking (92.35) Submitted: 8/17/2009 1:16:14 PM : Start Price: $3.72 SCLN Score: -46.44

This stock is on a definite upward trajectory, with heavy trading volume. A 93 IBD rating, Price/Sales ratio of 2.62 and Price/Book ratio of 3.55 make this a somewhat low risk investment.

snowcake (< 20) Submitted: 6/10/2009 12:00:48 PM : Start Price: $2.24 SCLN Score: -7.62

They have som experimental drugs in R and D that are very close to approval along with those already on the market makes this one a buy.

SmokeyJoeSmokin (93.54) Submitted: 12/11/2007 11:57:07 AM : Start Price: $2.52 SCLN Score: +22.33

These guys have some great drugs in their pipeline. This is a cheap biotech to buy for the long term.

wahookiller (< 20) Submitted: 2/14/2007 12:30:15 AM : Start Price: $2.87 SCLN Score: +5.47

Putting a quality sells team in place in China to market it current product. This will allow them to expand on their already successful Zaxadin medication and they will be in place for their new products and could possibly market other newly approved meds.

turingmouse (71.99) Submitted: 12/26/2006 9:36:56 AM : Start Price: $3.23 SCLN Score: -6.25

good cancer trials

cfromberg (71.27) Submitted: 12/25/2006 6:01:27 AM : Start Price: $3.33 SCLN Score: -8.88

new managment is very capable of turning the comapany into a hidden gem.

cjhpmh (56.01) Submitted: 12/9/2006 1:03:47 PM : Start Price: $2.38 SCLN Score: +21.45

China sales are up and melanoma trial results in Europe are due soon.